# Efficacy Study of Apremilast (CC-10004) in Subjects With Erosive Hand Osteoarthritis

> **NCT01200472** · PHASE2 · COMPLETED · sponsor: **University of Erlangen-Nürnberg Medical School** · enrollment: 30 (actual)

## Conditions studied

- Erosive Osteoarthritis of the Hand

## Interventions

- **DRUG:** Apremilast
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01200472
- **Lead sponsor:** University of Erlangen-Nürnberg Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2013-08
- **Final completion:** 2013-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2013-10-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01200472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01200472, "Efficacy Study of Apremilast (CC-10004) in Subjects With Erosive Hand Osteoarthritis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01200472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*